Brief: Orchestra BioMed Q3 EPS USD -0.37
Nov 13 (Reuters) - Orchestra BioMed Q3 EPS USD -0.37. * Q3 net income USD -13.3 million * Q3 revenue USD 400 thousand
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens